Kunju M Subair,Prabha Nini Gupta,K Suresh et al.
Kunju M Subair et al.
Objectives: To study the natural history of medically treated patients with endomyocardial fibrosis (EMF) and to see whether the usage of common drugs affected survival. ...
Smoking is associated with reduced serum paraoxonase, antioxidants and increased oxidative stress in normolipidaemic acute myocardial infarct patients [0.03%]
吸烟可引起正常血脂水平的急性心肌梗死患者的血清胆碱酯酶、抗氧化物降低和氧化应激升高
Arun Kumar,Utpal Kumar Biswas
Arun Kumar
Background: Paraoxonase is a high-density lipoprotein (HDL)-associated enzyme that protects lipoproteins from oxidative modifications and from becoming atherogenic in nature. Smoking is a well-known major cardiovascular r...
Vivian W Y Lee,Sally L T Law
Vivian W Y Lee
Background: Coronary heart disease (CHD) is a major health issue in Hong Kong and has become the second leading cause of death since the 1960s. The prevalence of CHD and its mortality in Hong Kong are approaching a level ...
Sex differences in hospital mortality following acute myocardial infarction in China: findings from a study of 45 852 patients in the COMMIT/CCS-2 study [0.03%]
中国急性心肌梗死患者的住院死亡性别差异——来自COMMIT/CCS-2研究的45852例患者分析
Yiping Chen,Lixin Jiang,Margaret Smith et al.
Yiping Chen et al.
Objective: To assess the sex difference in hospital mortality following ST elevation myocardial infarction (STEMI) in China. Design: Ob...
Lipid-lowering therapy using statins in patients with cardiovascular risk in clinical practice in Thailand [0.03%]
泰国临床实践中他汀类药物降低心血管风险患者血脂的治疗效果
Songkwan Silaruks,Charn Sriratanasathavorn,Petch Rawdaree et al.
Songkwan Silaruks et al.
Background: Since the release in Thailand in 2001 of the Third Guidelines by the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults or the...
Risk-factor profile, drug usage and cardiovascular events within a year in patients with and at high risk of atherothrombosis recruited from Asia as compared with those recruited from non-Asian regions: a substudy of the REduction of Atherothrombosis for Continued Health (REACH) registry [0.03%]
亚洲与非亚洲地区高危动脉粥样硬化血栓形成患者的一年内心血管事件：来自减少动脉粥样硬化血栓形成继续健康（REACH）注册表的亚研究结果
S Goto,Y Ikeda,J C N Chan et al.
S Goto et al.
Objective: To clarify the differences in the baseline characteristics, prevalence and incidence of atherothrombosis in patients recruited from Asia versus non-Asian regions. ...
Incomplete Kawasaki disease: early findings consist of congestive heart failure due to valvular heart disease [0.03%]
川崎病不完全型的早期表现是以心脏瓣膜病导致的心力衰竭为主要特征
Takashi Honda,Shohei Ogata,Masahiro Ishii
Takashi Honda
Case Reports
Heart Asia. 2011 Jan 1;3(1):92. DOI:10.1136/heartasia-2011-010002 2011
Tackling cardiovascular health and disease in Nepal: epidemiology, strategies and implementation [0.03%]
尼泊尔心血管健康与疾病的防治：流行病学、策略及实施
Abhinav Vaidya
Abhinav Vaidya
Cardiovascular diseases (CVDs) have now been finally recognised as a major public health issue in Nepal. This small landlocked South Asian country has an abundance of harmful risk factors that lead to CVD and the country lacks a system to m...
Comparison of efficacy and adverse effect profile of high dose versus standard dose atorvastatin in acute ST elevation myocardial infarction patients [0.03%]
高剂量阿托伐他汀与常规剂量阿托伐他汀治疗急性ST段抬高心梗患者的疗效及不良反应的对比研究
Gailin B Sebastian,T M Anoop,Joby K Thomas et al.
Gailin B Sebastian et al.
Objective: To compare the efficacy and adverse effects of high and standard dose atorvastatin in ST elevation myocardial infarction (STEMI) patients. Desi...
Prevalence and treatment of cardiovascular risk factors in outpatients with atherothrombosis in the Middle East [0.03%]
中东地区动脉粥样硬化性疾病的门诊患者的危险因素的流行率及治疗状况研究
Alawi A Alsheikh-Ali,Wael A Al-Mahmeed,Avi Porath et al.
Alawi A Alsheikh-Ali et al.
Objective: To characterise the risk-factor profile and treatment gaps among patients with, or at risk for, cardiovascular disease in the Middle East. Desi...